Atlas Trials

Effect of Trimetazidine on Radiotherapy-induced Heart Damage.

Clinical trial NCT04939857 · UNKNOWN

Trial details

NCT number
NCT04939857
Sponsor
Peking University Third Hospital
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Cardiotoxicity
Start date
2021-06-25
Primary completion
2022-07-30
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.